Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India

This publication has 25 references indexed in Scilit:

• Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
  Vaccine, 2008
• Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination
  Population Health Metrics, 2007
• The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting
  British Journal of Cancer, 2007
• Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
  The Lancet Infectious Diseases, 2007
• Effectiveness, safety and acceptability of ‘see and treat’ with cryotherapy by nurses in a cervical screening study in India
  British Journal of Cancer, 2007
• A comparative profile of the prevalence and age distribution of human papillomavirus type 16/18 infections among three states of India with focus on northeast India
  International Journal of Gynecologic Cancer, 2007
• Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: Results from a multicenter study in India
  International Journal of Cancer, 2004
• Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India
  International Journal of Gynecologic Cancer, 2004
• Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
  New England Journal of Medicine, 2003
• Estimating CE Ratios under Second-order Uncertainty
  Medical Decision Making, 1997